SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-014913
Filing Date
2023-05-01
Accepted
2023-05-01 14:01:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 31494
2 formdefa14-a_001.jpg GRAPHIC 430227
3 formdefa14-a_002.jpg GRAPHIC 320940
  Complete submission text file 0001493152-23-014913.txt   1067154
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36457 | Film No.: 23872495
SIC: 2834 Pharmaceutical Preparations